InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Kaiser Peter. Director active across 2 companies, notably Ocular Therapeutix, INC. Cumulatively, 10 reports have been published. Breakdown: 0 buy · 8 sells. Total volume traded: €265k. Activity tracked since 2 October 2024. The latest transaction was disclosed on 24 August 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations
Kaiser Peter is Chief Development Officer at OCULAR THERAPEUTIX, INC and Ocular Therapeutix, INC. He has filed 9 transactions in total, and across the recent filings available between 2024-10-04 and 2026-02-25, the reported sell amount is EUR 236621, with the transaction nature listed as Cession.